Informatie:
Fout:
ID
27395
Beschrijving
PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT00548093
Link
https://clinicaltrials.gov/show/NCT00548093
Trefwoorden
Versies (1)
- 13-11-17 13-11-17 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
13 november 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Carcinoma, Non Small Cell Lung NCT00548093
Eligibility Carcinoma, Non Small Cell Lung NCT00548093
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Non Small Cell Lung NCT00548093
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Non-Small Cell Lung Carcinoma Advanced
Item
advanced non-small cell lung cancer (nsclc)
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205179 (UMLS CUI [1,2])
Chemotherapy Regimen Quantity failed | erlotinib
Item
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1135135 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1135135 (UMLS CUI [2])
Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy
Item
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
C1265611 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
Measurable Disease
Item
measurable disease .
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)
Item
tissue available for kras/ egfr testing
boolean
C1292533 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3537133 (UMLS CUI [1,3])
C1292533 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
C3497772 (UMLS CUI [2,3])
C0470187 (UMLS CUI [1,2])
C3537133 (UMLS CUI [1,3])
C1292533 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
C3497772 (UMLS CUI [2,3])
Creatinine clearance measurement | Creatinine measurement, serum
Item
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
boolean
C0373595 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201976 (UMLS CUI [2])
Chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
Therapeutic radiology procedure
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
Biological Factors | Investigational New Drugs
Item
biological or investigational agents within 4 weeks of baseline disease assessment.
boolean
C0005515 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])
Intolerance to erlotinib
Item
patients who lack of tolerance of erlotinib therapy.
boolean
C1744706 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
C1135135 (UMLS CUI [1,2])